That is false information. I worked for 3M, the company that developed the Code 3 software which has been used for 25 plus years as the DRG vehicle to charge procedures that have been performed by providers. Obtaining the DRG code by the FDA is a prerequisite to the provider knowing they will get reimbursed when performing a procedure for a patient, be it a imaging, lab, drug injection procedure, etc. The fact that the FDA gave Cytodyn a code indicates that Leronlimab is being considered for approval and if approved they want the code ready. It does not indicate that approval has been given to them yet, that would come from the EUA by the FDA.